{"nct_id":"NCT04463771","title":"Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy.","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-06","start_date":"2021-01-26","start_date_type":"ACTUAL","primary_completion_date":"2026-04-14","primary_completion_date_type":"ESTIMATED","completion_date":"2026-07-10","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["INCY"]}